Inhibiting Different News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

30.04.2024 - Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter “Valerio Therapeutics” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage .

San antonioUnited statesRobert colemanNicolas treboutaAmerican association for cancer researchCompany groupNext oncologyValerio therapeuticsTargeting multiple proteinsRepair pathwaysInhibiting differentAmerican associationCancer researchInvestigational new drugAnnual general meetingEuronext growth paris

Valerio Therapeutics S A : Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

Valerio Therapeutics S A : Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan antonioRobert colemanNicolas treboutaShefali agarwalAmerican association for cancer researchCompany groupEuronext growth parisValerio therapeuticNext oncologyValerio therapeuticsTargeting multiple proteins repair pathwaysInhibiting differentAmerican associationCancer researchInvestigational new drug

Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

Cash position of €6.8 million as of December 31, 2023 Financial visibility until the end of fourth quarter of 2024 .

United statesSan antonioShefali agarwalNicolas treboutaRobert colemanAmerican association for cancer researchCompany groupRegulatory newsEuronext growth parisValerio therapeuticNext oncologyValerio therapeuticsTargeting multiple proteinsRepair pathwaysInhibiting differentAmerican association

Valerio Therapeutics S A : Valerio Therapeutics Reports its Half-Year 2023 Financial Results and Provides an Update on its Activities

Valerio Therapeutics S A : Valerio Therapeutics Reports its Half-Year 2023 Financial Results and Provides an Update on its Activities
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNicolas fossiezRobert colemanGustave roussyShefali agarwalNicolas treboutaInstitut curieArthur rouillAgenus incEuropean unionAmerican association for cancer researchCompany groupSafety monitoring committeeEuronext growth parisValerio therapeuticsInvus public equities